1. Polymer vesicles for the delivery of inhibitors of cariogenic biofilm.
- Author
-
Ahirwar, Parmanand, Kozlovskaya, Veronika, Pukkanasut, Piyasuda, Nikishau, Pavel, Nealy, Sarah, Harber, Gregory, Michalek, Suzanne M., Antony, Linto, Wu, Hui, Kharlampieva, Eugenia, and Velu, Sadanandan E.
- Subjects
- *
CAVITY prevention , *DRUG delivery systems , *LABORATORY rats , *CARIOGENIC agents , *STREPTOCOCCUS mutans , *DENTAL caries - Abstract
The goal of this study is to develop a novel drug delivery platform for the pH-responsive delivery of biofilm inhibitors as a potential avenue to prevent and treat dental caries. Biofilm and growth inhibition assays were performed in polystyrene microtiter 96-well plates. Docking analysis was performed using the reported GtfB + HA5 co-crystal structure (PDB code: 8fg8) in SeeSAR 13.0.1 software. Polymersome vesicles were assembled from poly(N-vinylpyrrolidone) 8 - block -poly(dimethylsiloxane) 64 - block -poly(N-vinylpyrrolidone) 8 (PVPON 8 -PDMS 64 -PVPON 8) triblock copolymer using a nanoprecipitation method. Microbiome analysis of biofilm inhibitors and the in vivo drug release and antivirulence activities of polymersome encapsulated inhibitors have been carried out in a S. mutans induced rat caries model. Biofilm inhibitors for HA5 and HA6 have shown species-specific selectivity towards S. mutans and the ability to preserve the oral microbiome in a S. mutans induced dental caries model. The inhibitors were encapsulated into pH-responsive block copolymer vesicles to generate polymersome-encapsulated biofilm inhibitors, and their biofilm and growth inhibitory activities against S. mutans and representative strains of oral commensal streptococci have been assessed. A 4-week treatment of S. mutans UA159 infected gnotobiotic rats with 100 µM of polymersome-encapsulated biofilm inhibitor, PEHA5 showed significant reductions in buccal, sulcal, and proximal caries scores compared to an untreated control group. Taken together, our data suggests that the biofilm-selective therapy using the polymersome-encapsulated biofilm inhibitors is a viable approach for the prevention and treatment of dental caries while preserving the oral microbiome. [Display omitted] • Biofilm inhibitors HA5 and HA6 have species-specific selectivity towards S. mutans. • HA5 and HA6 preserve the oral microbiome as demonstrated in a rat caries model. • pH sensitive polymersome encapsulated PEHA5 and PEHA6 were prepared. • PEHA5 showed significant reduction of caries scores in a rat caries model. • Biofilm-selective therapy is a viable approach for dental caries prevention. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF